Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 6/2018

01-06-2018 | Editorial

Reducing Long-term Opioid Use in the Veterans Health Administration

Authors: Taeko Minegishi, MS, Austin Frakt, PhD

Published in: Journal of General Internal Medicine | Issue 6/2018

Login to get access

Excerpt

In 2015, 25% of US adults had at least one opioid prescription. In the same year, over 33,000 people died of opioids and approximately 40% were attributed to opioid prescriptions,1 contributing to what the Centers for Disease Control and Prevention (CDC) termed an “epidemic.” Long-term opioid use is particularly problematic, associated with much higher rates of misuse and overdose than short-term use.2 As we reconsider the appropriate role of opioids in medical care, experts have called for an effort to minimize the initiation of long-term use and to taper long-term patients off opioids, when warranted. …
Literature
1.
Center for Disease Control and Prevention. Annual Surveillance Report of Drug-Related Risks and Outcomes - United States, 2017. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2017.
2.
Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181–191.CrossRefPubMed
3.
Edlund MJ, Austen MA, Sullivan MD, et al. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011: Pain. 2014;155(11):2337–2343.CrossRefPubMedPubMedCentral
4.
Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947.CrossRefPubMed
5.
Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611–612.CrossRefPubMed
6.
7.
Gallagher RM. Advancing the pain agenda in the Veteran population. Anesthesiol Clin. 2016;34(2):357–378.CrossRefPubMed
8.
Minegishi T, Frakt AB, Garrido MM, et al. Randomized program evaluation of the VHA Stratification Tool for Opioid Risk Mitigation (STORM): a research and clinical operations partnership to examine effectiveness. Subst Abuse. 2018 (in press).
9.
Minegishi T, Garrido MM, Pizer SD, Frakt AB. The Effectiveness of Policy and Risk Targeting for Opioid-Related Risk Mitigation: A Randomized Program Evaluation. BMJ Open. 2018 (in press).
10.
Thielke SM, Turner JA, Shortreed SM, et al. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. March 2013:1.
Metadata
Title
Reducing Long-term Opioid Use in the Veterans Health Administration
Authors
Taeko Minegishi, MS
Austin Frakt, PhD
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4352-7

Other articles of this Issue 6/2018

Journal of General Internal Medicine 6/2018 Go to the issue

Original Research

Physician Perception of Pay Fairness and its Association with Work Satisfaction, Intent to Leave Practice, and Personal Health

Capsule Commentary

Capsule Commentary on Robinson et al.: A Randomized Trial on the Efficacy of Mastery Learning on Primary Care Providers’ Melanoma Opportunistic Screening Skills and Practice

Letter to the Editor

Response to Capsule Commentary on Merlin et al., Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study

Original Research

Women’s Healthcare Utilization Following Routine Screening for Past-Year Intimate Partner Violence in the Veterans Health Administration

Clinical Practice: Clinical Images

Chronic Abdominal Pain from Disseminated Splenosis

Original Research

Effects of Sleep, Physical Activity, and Shift Work on Daily Mood: a Prospective Mobile Monitoring Study of Medical Interns
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits